We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine

By LabMedica International staff writers
Posted on 05 Feb 2020
Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre. More...
As the MENA region’s largest medical laboratory exhibition and congress, MEDLAB Middle East plays a crucial role in developing the value of laboratory medicine in transforming tomorrow’s diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers and distributors, to share best practice, showcase new innovations, collaborate and network. MEDLAB Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Moving into its 4th year as a stand-alone show, this annual medical laboratory meeting brings together exhibitors and attendees from over 135+ countries, giving them the opportunity to present the latest innovations, as well as access cutting-edge laboratory products and services.

With laboratory services in the MEA region expected to grow at a compound annual growth rate (CAGR) of 3.8% until 2023, the 2020 edition of the show witnessed an increase in both the value of business and the number of attendees in comparison to last year. The four-day show organized by Informa Markets hosted the inaugural Transformation Hub, a dedicated zone showcasing advanced clinical laboratory products by the SMEs and new-to-market pioneers that are transforming diagnostics and advancing healthcare. The zone also featured the Transformation Talks sessions where manufacturers introduced new launches and in-demand solutions. Some of the key areas that were highlighted at the Transformation Hub included automation, healthcare information technology (HIT) and laboratory measurement testing and technology.

In addition to the Transformation Hub, MEDLAB Middle East also hosted a series of free-to-attend workshops, hosted by the National Reference Laboratory (NRL) and Bio-Rad, where a hands-on approach to learning and knowledge-sharing on new product offerings, technology and best practice took place. Workshops included Transfusion and blood typing challenges; Laboratory quality management system, the best of CLSI; and Laboratory accreditation, CAP updates.

MEDLAB Middle East also offered an educational agenda for clinical laboratory specialists to advance their skill sets, inspire and to provide advanced medical laboratory techniques for better health. More than 4,500 conference delegates had the opportunity to hear from 120 speakers from around the world, across 12 Continuing Medical Education (CME) accredited conferences.

The 2020 edition of the show saw the introduction of four new conference tracks, including Blood Transfusion Medicine, Laboratory Innovation, Digital Pathology and the Roundtable Discussions, which featured focused scientific group discussions on selected administration and technical topics in the medical laboratory.

“MEDLAB Middle East provides the ideal platform to showcase groundbreaking products to the medical laboratory industry here in the Middle East, while also sharing research and educational initiatives to visitors and delegates from around the word,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
STI Test
RIDA GENE STI Mycoplasma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.